APOTHEEK DRIE KONINGEN
ActiveAPOTHEEK DRIE KONINGEN has been active since 2002 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €357k and a net result of €159k. Equity is growing by ~27.8% per year across the filed fiscal years. Its solvency ranks better than 66% of 10310 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (very low).
Checked score
Score 2025
81
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability98▲+7
Solvency78▲+16
Growth78=
Track record100
Bankruptcy probability, 12 months
0.5%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €25k at 30 days acceptable
Liquidity ample (current ratio 2.92 against 1.82 in 2024; short-term debt: 22.5% and cash: 14.4% of total assets), and 46.9% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
53.1%
Return on assets
23.6%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 12-08-2026, 12 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
12 d late
2024
3 d early
2023
29 d late
2022
28 d late
2021
19 d late
2020
25 d late
2019
11 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
19-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€357k▲ 38.4%
2024 · €258k
2018: €77k
2019: €79k
2020: €79k
2021: €85k
2022: €111k
2023: €181k
2024: €258k
2018 → 2025
Total assets
€673k▼ 2.2%
2024 · €688k
2018: €803k
2019: €768k
2020: €712k
2021: €713k
2022: €660k
2023: €774k
2024: €688k
2018 → 2025
Net result
€159k▲ 30.7%
2024 · €122k
2018: €39k
2019: €57k
2020: €59k
2021: €106k
2022: €159k
2023: €126k
2024: €122k
2018 → 2025
Working capital
€291k▲ 46.7%
2024 · €198k
2018: €168k
2019: €165k
2020: €164k
2021: €108k
2022: €109k
2023: €124k
2024: €198k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€85k-€111k▲ 30.4%€181k▲ 64.1%€258k▲ 42.3%€357k▲ 38.4%
Operating result€120k-€180k▲ 49.8%€162k▼ 10.3%€162k▲ 0.2%€202k▲ 24.8%
Net result€106k-€159k▲ 50.4%€126k▼ 20.7%€122k▼ 3.2%€159k▲ 30.7%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 25% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €673k
Fixed assets
€231k▼ 6.7%
Current assets
€442k▲ 0.3%
Equity and liabilities €673k
Equity
€357k▲ 38.4%
Debt
€316k▼ 26.6%
The debt ratio falls from 62.5% to 46.9%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€221k▲
2024 · €184k
Cash flow
€178k▲
2024 · €143k
Solvency
53.1%▲
2024 · 37.5%
Current ratio
2.92▲
2024 · 1.82
Quick ratio
1.62▲
2024 · 1.08
Debt / equity
0.88▼
2024 · 1.67
ROE
44.5%▼
2024 · 47.2%
ROA
23.6%▲
2024 · 17.7%
Interest coverage
26.68▲
2024 · 13.98
Debt
€316k▼
2024 · €430k
Debt ≤ 1 year
€152k▼
2024 · €243k
Debt > 1 year
€161k▼
2024 · €182k
Income taxes
€35k▲
2024 · €27k
Staff costs
€80k▼
2024 · €90k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€688k€673k▼
Fixed assets21/28€248k€231k▼
Tangible fixed assets22/27€248k€231k▼
Land and buildings22€242k€226k▼
Plant, machinery and equipment23€3k€4k▲
Furniture and vehicles24€2k€2k▼
Current assets29/58€441k€442k▲
Stocks and contracts in progress3€179k€197k▲
Stocks30/36€179k€197k▲
Amounts receivable within one year40/41€87k€137k▲
Trade receivables40€84k€120k▲
Other amounts receivable41€3k€17k▲
Cash at bank and in hand54/58€163k€97k▼
Deferred charges and accrued income490/1€12k€12k▼
Equity and liabilities
Total equity and liabilities10/49€688k€673k▼
Equity10/15€258k€357k▲
Contributions10/11€19k€19k=
Reserves13€240k€339k▲
Tax-exempt reserves132€140€140=
Distributable reserves133€239k€339k▲
Profit (loss) carried forward14€0€0=
Amounts payable17/49€430k€316k▼
Amounts payable after more than one year17€182k€161k▼
Financial debts170/4€182k€161k▼
Amounts payable within one year42/48€243k€152k▼
Current portion of amounts payable after more than one year42€20k€21k▲
Trade debts44€59k€60k▲
Suppliers440/4€59k€60k▲
Taxes, remuneration and social security45€16k€10k▼
Taxes450/3€1k€667▼
Remuneration and social security454/9€15k€9k▼
Other amounts payable47/48€147k€61k▼
Accrued charges and deferred income492/3€6k€3k▼
Income statement
Code20242025
Remuneration, social security and pensions62€90k€80k▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€22k€19k▼
Other operating charges640/8€535€751▲
Non-recurring operating charges66A-€561
Gross operating margin9900€274k€302k▲
Operating profit (loss)9901€162k€202k▲
Financial income75/76B€0€4▲
Recurring financial income75€0€4▲
Financial charges65/66B€13k€8k▼
Recurring financial charges65€13k€8k▼
Profit (loss) for the period before taxes9903€149k€194k▲
Income taxes67/77€27k€35k▲
Profit (loss) for the period9904€122k€159k▲
Profit (loss) for the period to be appropriated9905€122k€159k▲
Appropriation of the result
Profit (loss) to be appropriated9906€122k€159k▲
Transfer to equity691/2€77k€99k▲
To other reserves6921€77k€99k▲
Profit to be distributed694/7€45k€60k▲
Directors or managers695€45k€60k▲
Social balance
Average headcount (FTE)90871.51.5=
The notes to these accounts (15 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
12-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 12 days late
2025
31-12
Financial
Highest result since 2018net €159k ▲30.7%
Operating result €202k, net result €159k, both a record.
28-07
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial
Equity above €200kEq €258k ▲42.3%
7 profitable years in a row build equity to €258k.
29-08
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema · 29 days late
2023
31-12
Financial
Equity above €150kEq €181k ▲64.1%
6 profitable years in a row build equity to €181k.
28-08
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 28 days late
2022
31-12
Financial
Equity above €100kEq €111k ▲30.4%
5 profitable years in a row build equity to €111k.
19-08
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 19 days late
2021
25-08
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 25 days late
2020
11-08
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 11 days late
2019
16-08
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 16 days late
2018
14-08
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema · 14 days late
2017
02-08
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 2 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Antwerpen · 1 establishment unit since 2003
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Grotesteenweg 992600 AntwerpenGround area
1,264 m²
Building footprint
593 m²
Volume, LiDAR
6,618 m³
Parcel 11303B0562/00F000, Flanders · tallest building 35.9 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
APOTHEEK DRIE KONINGEN
since 20032.114.797.760
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11303B0562/00F000 | Flanders | 1,264 m² | 1 · 593 m² | 35.9 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2024 · 1 entry · 2,000 EUR awarded · 2,000 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2024 | 1 | 2,000 EUR | 2,000 EUR |
Schemes
Hinderpremie bij openbare werken
Recognitions · licences · registrations
Food safety, FASFC
1 siteAntwerpen2.114.797.760
Similar companies · same sector, comparable size
V-cares
BE 0766.262.782
Zonhoven · Eq €357k
DIAPHARMA
BE 0474.698.006
Leuven · Eq €357k
APOTHEEK VERSYCK AN
BE 0829.107.005
Knokke-Heist · Eq €357k
APOTHEEK TER PLATEN
BE 0430.057.220
Gent · Eq €357k
PHARMANEMA
BE 0479.052.415
Leuven · Eq €358k
Of 5,222 companies in sector 47730 we hold annual accounts for 3,861. 3,462 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded28-11-2002
Fiscal year end31-12
Abbreviation NL
APOTHEEK 3K
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
Sources
Crossroads Bank for EnterprisesNational Bank · 23 filingsAddress and cadastre registers
Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.